NextCure, Inc. — Director's Dealing 2019

May 14, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NextCure, Inc. (NXTC)
CIK: 0001661059
Period of Report: 2019-05-13

Reporting Person: Alexandria Venture Investments, LLC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-13	Common Stock	C	197993	—	Acquired	197993	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-13	Series A-1 Preferred Stock	$	C	223500	Disposed		Common Stock (27819.0)	Direct
2019-05-13	Series A-2 Preferred Stock	$	C	372500	Disposed		Common Stock (46366.0)	Direct
2019-05-13	Series A-3 Preferred Stock	$	C	365727	Disposed		Common Stock (45523.0)	Direct
2019-05-13	Series B-1 Preferred Stock	$	C	628931	Disposed		Common Stock (78285.0)	Direct

Footnotes

F1: Each share of preferred stock was convertible into the Issuer's common stock at a ratio of 8.0338 shares of preferred stock to 1 share of common stock, and converted automatically upon the closing of the Issuer's initial public offering, for no additional consideration. The shares had no expiration date.

F2: Not applicable